References
- Tarabishy AB, Hise AG, Traboulsi EI. Ocular manifestations of the autoinflammatory syndromes. Ophthalmic Genet. 2012;33(4):179–186. doi:10.3109/13816810.2012.695421.
- Petrushkin H, Stanford M, Fortune F, Jawad AS. Clinical review: familial mediterranean fever-an overview of pathogenesis, symptoms, ocular manifestations, and treatment. Ocul Immunol Inflamm. 2016;24:422–430. doi:10.3109/09273948.2015.1010012.
- Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, et al. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS). Ann Rheum Dis. 2017;76(6):942–947. doi:10.1136/annrheumdis-2016-209686.
- Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinfl ammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301–305. doi:10.1038/ng756.
- Cuisset L, Drenth JP, Berthelot JM, et al. Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet. 1999;65:1054–1059. doi:10.1086/302589.
- Cuisset L, Jeru I, Dumont B, et al. Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis. 2011;70(3):495–499. doi:10.1136/ard.2010.138420.
- Lainka E, Neudorf U, Lohse P, et al. Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children. Rheumatol Int. 2012;32:3253–3260. doi:10.1007/s00296-011-2180-8.
- Goldfinger S. The inherited autoinflammatory syndrome: a decade of discovery. Trans Am Clin Climatol Assoc. 2009;120:413–418.
- Shakeel A, Gouws P. Muckle-Wells syndrome: another cause of acute anterior uveitis. Eye. 2007;21:849–850. doi:10.1038/sj.eye.6702704.
- Oberg TJ, Vitale AT, Hoffman RO, Bohnsack JF, Warner JE. Cryopyrin-associated periodic syndromes and the eye. Ocul Immunol Inflamm. 2013;21(4):306–309. doi:10.3109/09273948.2013.765016.
- Safarzadeh M, Nasiri N. Anterior segment characteristics in normal and keratoconus eyes evaluated with a combined Scheimpflug/Placido corneal imaging device. J Curr Ophthalmol. 25, 2016;28:106–111. doi:10.1016/j.joco.2016.06.003.
- Neven B, Prieur AM, Quartier dit Maire P. Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol. 2008;4:481–489. doi:10.1038/ncprheum0874.
- Kümmerle-Deschner JB, Tyrrell PN, Reess F, et al. Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum. 2010;62(12):3783–3791. doi:10.1002/art.27696.
- Tran TA. Muckle–wells syndrome: clinical perspectives. Open Access Rheumatol. 2017;9:123–129. doi:10.2147/OARRR.S114447.
- Hirano M, Seguchi J, Yamamura M, et al. Successful resolution of stromal keratitis and uveitis using canakinumab in a patient with chronic infantile neurologic, cutaneous and articular syndrome: a case study. J Ophthalmic Inflamm Infect. 2015;5(1):34. doi:10.1186/s12348-015-0065-9.
- Kuemmerle-Deschner JB, Tyrrell PN, Koetter I, et al. Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome. Arthritis Rheum. 2011;63(3):840–849. doi:10.1002/art.30149.
- Kitley JL, Lachmann HJ, Pinto A, Ginsberg L. Neurologic manifestations of the cryopyrin-associated periodic syndrome. Neurology. 2010;74:1267–1270. doi:10.1212/WNL.0b013e3181d9ed69.
- Mortimer L, Moreau F, MacDonald JA, Chadee K. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. Nat Immunol. 2016;17:1176–1186. doi:10.1038/ni.3538.
- Gorovoy IR, Gorovoy JB, Salomao D, Gorovoy MS. Chronic keratitis with intrastromal epithelioid histiocytes: a new finding in Muckle-Wells syndrome. Cornea. 2013;32:510–512. doi:10.1097/ICO.0b013e3182784ad3.
- Boutboul S, Basli E, Gaujoux T, et al. OCT and HRT analysis of the cornea in Muckle-Wells syndrome. Invest Ophthalmol Vis Sci. 2011;149:1083.
- Alexander T, Klotz O, Feist E, Rüther K, Burmester GR, Pleyer U. Successful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonist. Ann Rheum Dis. 2005;64:1245–1246. doi:10.1136/ard.2004.032060.
- Terrada C, Neven B, Boddaert N, et al. Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra. J Ophthalmic Inflamm Infect. 2011;1(3):133–136. doi:10.1007/s12348-010-0018-2.
- Caorsi R, Lepore L, Zulian F, et al. The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age. Arthritis Res Ther. 26, 2013;15:R33. doi:10.1186/ar4184.